136
Views
0
CrossRef citations to date
0
Altmetric
Preliminary Communication

Radiologically Isolated Syndrome: Targeting miRNAs as Prognostic Biomarkers

ORCID Icon, , ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon & ORCID Icon show all
Pages 2065-2076 | Received 28 Apr 2020, Accepted 04 Oct 2020, Published online: 08 Dec 2020

References

  • Okuda DT , MowryEM , BeheshtianAet al. Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology72(9), 800–805 (2009).
  • Okuda DT . Radiologically isolated syndrome. Neuroimaging Clin. N. Am.27(2), 267–275 (2017).
  • Thouvenot E , HinsingerG , DematteiCet al. Cerebrospinal fluid chitinase-3-like protein 1 level is not an independent predictive factor for the risk of clinical conversion in radiologically isolated syndrome. Mult Scler25(5), 669–677 (2019).
  • Matute-Blanch C , VillarLM , Álvarez-CermeñoJCet al. Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome. Brain141(4), 1085–1093 (2018).
  • Mendell JT , OlsonEN. MicroRNAs in stress signaling and human disease. Cell148(6), 1172–1187 (2012).
  • Ebrahimkhani S , VafaeeF , YoungPEet al. Exosomal microRNA signatures in multiple sclerosis reflect disease status. Sci. Rep.7(1), 14293 (2017).
  • Vistbakka J , ElovaaraI , LehtimäkiT , HagmanS. Circulating microRNAs as biomarkers in progressive multiple sclerosis. Mult. Scler. J.23(3), 403–412 (2017).
  • Quintana E , OrtegaFJ , Robles-CedeñoRet al. miRNAs in cerebrospinal fluid identify patients with MS and specifically those with lipid-specific oligoclonal IgM bands. Mult. Scler. J.23(13), 1716–1726 (2017).
  • Fenoglio C , DeRiz M , PietroboniAMet al. Effect of fingolimod treatment on circulating miR-15b, miR23a and miR-223 levels in patients with multiple sclerosis. J. Neuroimmunol.299, 81–83 (2016).
  • Sádaba MC , GonzálezPorqué P , MasjuanJ , Alvarez-CermeñoJC , BootelloA , VillarLM. An ultrasensitive method for the detection of oligoclonal IgG bands. J. Immunol. Methods284(1–2), 141–145 (2004).
  • Ortega FJ , MercaderJM , CatalanVet al. Targeting the circulating microRNA signature of obesity. Clin. Chem.59(5), 781–792 (2013).
  • de Ronde MWJ , RuijterJM , LanfearDet al. Practical data handling pipeline improves performance of qPCR-based circulating miRNA measurements. RNA23(5), 811–821 (2017).
  • Marabita F , de CandiaP , TorriA , TegnérJ , AbrignaniS , RossiRL. Normalization of circulating microRNA expression data obtained by quantitative real-time RT-PCR. Brief. Bioinform.17(2), 204–212 (2016).
  • Mestdagh P , Van VlierbergheP , DeWeer Aet al. A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol.10(6), R64 (2009).
  • Chou CH , ShresthaS , YangCDet al. miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions. Nucleic Acids Res.46(D1), D296–D302 (2018).
  • Kuleshov MV , JonesMR , RouillardADet al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res.44(W1), W90–W97 (2016).
  • Supek F , BošnjakM , ŠkuncaN , ŠmucT. REVIGO summarizes and visualizes long lists of gene ontology terms. PLoS ONE6(7), e21800 (2011).
  • Ludwig N , LeidingerP , BeckerKet al. Distribution of miRNA expression across human tissues - PubMed. Nucleic Acids Res.44(8), 3865–3877 (2016).
  • Lizio M , HarshbargerJ , ShimojiHet al. Gateways to the FANTOM5 promoter level mammalian expression atlas. Genome Biol.16(1), 22 (2015).
  • Murillo OD , ThistlethwaiteW , RozowskyJet al. exRNA atlas analysis reveals distinct extracellular RNA Cargo types and their carriers present across human biofluids. Cell177(2), 463–477.e15 (2019).
  • Pawlitzki M , Sweeney-ReedCM , BittnerDet al. CSF-progranulin and neurofilament light chain levels in patients with radiologically isolated syndrome-sign of inflammation. Front. Neurol.9, 1075 (2018).
  • Okuda DT , SivaA , KantarciOet al. Radiologically isolated syndrome: 5-year risk for an initial clinical event. PLoS ONE9(3), e90509 (2014).
  • Gandhi R , HealyB , GholipourTet al. Circulating MicroRNAs as biomarkers for disease staging in multiple sclerosis. Ann. Neurol.73(6), 729–740 (2013).
  • Siegel SR , MackenzieJ , ChaplinG , JablonskiNG , GriffithsL. Circulating microRNAs involved in multiple sclerosis. Mol. Biol. Rep.39(5), 6219–6225 (2012).
  • McDonald JS , MilosevicD , ReddiHV , GrebeSK , Algeciras-SchimnichA. Analysis of circulating MicroRNA: preanalytical and analytical challenges. Clin. Chem.57(6), 833–840 (2011).
  • Wang-Renault S-F , BoudaoudS , NocturneGet al. Deregulation of microRNA expression in purified T and B lymphocytes from patients with primary Sjögren’s syndrome. Ann. Rheum. Dis.77(1), 133–140 (2018).
  • Columb MO , AtkinsonMS. Statistical analysis: sample size and power estimations. BJA Education16(5), 159–161 (2016).
  • Wu R , HeQ , ChenHet al. MicroRNA-448 promotes multiple sclerosis development through induction of Th17 response through targeting protein tyrosine phosphatase non-receptor type 2 (PTPN2). Biochem. Biophys. Res. Commun.486(3), 759–766 (2017).
  • Junker A , KrumbholzM , EiseleSet al. MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain132(12), 3342–3352 (2009).
  • Wang H , MoyanoAL , MaZZet al. miR-219 Cooperates with miR-338 in myelination and promotes myelin repair in the CNS. Dev. Cell40(6), 566–582.e5 (2017).
  • Yang D , WangWZ , ZhangXMet al. MicroRNA expression aberration in Chinese patients with relapsing remitting multiple sclerosis. J. Mol. Neurosci.52(1), 131–137 (2014).
  • Martinelli-Boneschi F , FenoglioC , BrambillaPet al. MicroRNA and mRNA expression profile screening in multiple sclerosis patients to unravel novel pathogenic steps and identify potential biomarkers. Neurosci. Lett.508(1), 4–8 (2012).
  • Sievers C , MeiraM , HoffmannF , FontouraP , KapposL , LindbergRLP. Altered microRNA expression in B lymphocytes in multiple sclerosis. Towards a better understanding of treatment effects. Clin. Immunol.144(1), 70–79 (2012).
  • Keller A , LeidingerP , LangeJet al. Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls. PLoS ONE4(10), e7440 (2009).
  • Waschbisch A , AtiyaM , LinkerRA , PotapovS , SchwabS , DerfussT. Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis. PLoS ONE6(9), 1–5 (2011).
  • Weber JA , BaxterDH , ZhangSet al. The microRNA spectrum in 12 body fluids. Clin. Chem.56(11), 1733–1741 (2010).
  • Anoop A , SinghPK , JacobRS , MajiSK. CSF biomarkers for Alzheimer’s disease diagnosis. Int. J. Alzheimers. Dis.2010, 606802 (2010).
  • Valadi H , EkströmK , BossiosA , SjöstrandM , LeeJJ , LötvallJO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol.9(6), 654–659 (2007).
  • Zhang Y , LiuD , ChenXet al. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol. Cell39(1), 133–144 (2010).
  • Mycko MP , BaranziniSE. microRNA and exosome profiling in multiple sclerosis. Mult. Scler. J.26(5), 599–604 (2020).
  • De Stefano N , StromilloML , RossiFet al. Improving the characterization of radiologically isolated syndrome suggestive of multiple sclerosis. PLoS ONE6(4), e19452 (2011).
  • Cui M , WangH , YaoXet al. Circulating microRNAs in cancer: potential and challenge. Front. Genet.10, 626 (2019).
  • Høglund RA , MaghazachiAA. Multiple sclerosis and the role of immune cells. World J. Exp. Med.4(3), 27 (2014).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.